Amanote Research
Register
Sign In
Orphan Designation: Pomalidomide, Treatment of Multiple Myeloma
Case Medical Research
doi 10.31525/cmr-1584447
Full Text
Open PDF
Abstract
Available in
full text
Date
June 18, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Orphan Designation: Brincidofovir, Treatment of Smallpox
Case Medical Research
Orphan Designation: Melatonin, Treatment of Perinatal Asphyxia
Case Medical Research
Orphan Designation: Bertilimumab, Treatment of Bullous Pemphigoid
Case Medical Research
Orphan Designation: Dantrolene Sodium, Treatment of Wolfram Syndrome
Case Medical Research
Orphan Designation: Trientine Dihydrochloride, Treatment of Wilson's Disease
Case Medical Research
Orphan Designation: Eculizumab, Treatment of Paroxysmal Nocturnal Haemoglobinuria
Case Medical Research
Orphan Designation: Anetumab Ravtansine, Treatment of Ovarian Cancer
Case Medical Research
Daratumumab vs. Pomalidomide for the Treatment of Relapsed/Refractory Multiple Myeloma: A Cost‐effectiveness Analysis
American Journal of Hematology
Hematology
Orphan Designation: Mogamulizumab, Treatment of Cutaneous T-Cell Lymphoma
Case Medical Research
